NCT05275478 2026-04-15Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTango Therapeutics, Inc.Phase 1/2 Terminated110 enrolled
NCT05732831 2026-04-06Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsTango Therapeutics, Inc.Phase 1/2 Recruiting225 enrolled
NCT05642455 2026-02-09SPEARHEAD-3 Pediatric StudyUSWM, LLC (dba US WorldMeds)Phase 1/2 Recruiting20 enrolled